These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21562073)

  • 1. Letrozole withdrawal response in locally advanced breast cancer.
    Lambertini M; Pronzato P; Giraudi S; Levaggi A; Bighin C; Del Mastro L
    Ann Oncol; 2011 Aug; 22(8):1927-8. PubMed ID: 21562073
    [No Abstract]   [Full Text] [Related]  

  • 2. Do steroid hormones have an important role on cutaneous lupus physiopathology?
    Brasileiro A; Campos S; Fidalgo A
    An Bras Dermatol; 2015; 90(5):766-8. PubMed ID: 26560229
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized phase II trial of letrozole plus anti-MUC1 antibody AS1402 in hormone receptor-positive locally advanced or metastatic breast cancer.
    Ibrahim NK; Yariz KO; Bondarenko I; Manikhas A; Semiglazov V; Alyasova A; Komisarenko V; Shparyk Y; Murray JL; Jones D; Senderovich S; Chau A; Erlandsson F; Acton G; Pegram M
    Clin Cancer Res; 2011 Nov; 17(21):6822-30. PubMed ID: 21878535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis in patient with breast cancer receiving letrozole.
    Chia WK; Lim YL; Greaves MW; Ang P
    Lancet Oncol; 2006 Feb; 7(2):184-5. PubMed ID: 16455483
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer survivors.
    Boyle F; Forbes J
    Aust Fam Physician; 2008 Oct; 37(10):791. PubMed ID: 19013826
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative efficacy study of 5-year letrozole or anastrozole in postmenopausal hormone receptor-positive early breast cancer.
    Sendur MA; Aksoy S; Zengin N; Altundag K
    J BUON; 2013; 18(4):838-44. PubMed ID: 24344006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.
    Azria D; Belkacemi Y; Romieu G; Gourgou S; Gutowski M; Zaman K; Moscardo CL; Lemanski C; Coelho M; Rosenstein B; Fenoglietto P; Crompton NE; Ozsahin M
    Lancet Oncol; 2010 Mar; 11(3):258-65. PubMed ID: 20138810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
    Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of letrozole in postmenopausal women with hormone-responsive breast cancer.
    Barnadas A; Estévez LG; Lluch-Hernández A; Rodriguez-Lescure A; Rodriguez-Sanchez C; Sanchez-Rovira P
    Adv Ther; 2011 Dec; 28(12):1045-58. PubMed ID: 22068628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.
    Dombernowsky P; Smith I; Falkson G; Leonard R; Panasci L; Bellmunt J; Bezwoda W; Gardin G; Gudgeon A; Morgan M; Fornasiero A; Hoffmann W; Michel J; Hatschek T; Tjabbes T; Chaudri HA; Hornberger U; Trunet PF
    J Clin Oncol; 1998 Feb; 16(2):453-61. PubMed ID: 9469328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea.
    Beom SH; Oh J; Kim TY; Lee KH; Yang Y; Suh KJ; Moon HG; Han SW; Oh DY; Han W; Kim TY; Noh DY; Im SA
    Cancer Res Treat; 2017 Apr; 49(2):454-463. PubMed ID: 27554482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobular carcinoma of the breast metastasizing to leiomyoma in a patient under letrozole treatment.
    Işçi H; Güdücü N; Basgul AY; Aydinli K; Calay Z; Dünder I
    Eur J Gynaecol Oncol; 2011; 32(5):560-2. PubMed ID: 22053676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letrozole or tamoxifen in early breast cancer.
    Buzdar AU; Baum M; Cuzick J
    N Engl J Med; 2006 Apr; 354(14):1528-30; author reply 1528-30. PubMed ID: 16598051
    [No Abstract]   [Full Text] [Related]  

  • 14. Third-generation aromatase inhibitors in the treatment of advanced breast cancer.
    Nabholtz JM; Reese DM
    Breast Cancer; 2001; 8(4):305-9. PubMed ID: 11791122
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.
    Rasmussen BB; Regan MM; Lykkesfeldt AE; Dell'Orto P; Del Curto B; Henriksen KL; Mastropasqua MG; Price KN; Méry E; Lacroix-Triki M; Braye S; Altermatt HJ; Gelber RD; Castiglione-Gertsch M; Goldhirsch A; Gusterson BA; Thürlimann B; Coates AS; Viale G;
    Lancet Oncol; 2008 Jan; 9(1):23-8. PubMed ID: 18083065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overlooked Cardiac Adverse Effect of Letrozol Therapy: Myocardial Infarction due to Coronary Thrombus Formation.
    Yilmaz S; Avci S; Canpolat U; Başar FN
    Breast J; 2015; 21(4):440-1. PubMed ID: 25950726
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term outcomes of aromatase inhibition for breast cancer.
    Toi M
    Lancet Oncol; 2008 Jan; 9(1):8-10. PubMed ID: 18177815
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).
    Blok EJ; Kroep JR; Meershoek-Klein Kranenbarg E; Duijm-de Carpentier M; Putter H; van den Bosch J; Maartense E; van Leeuwen-Stok AE; Liefers GJ; Nortier JWR; Rutgers EJT; van de Velde CJH;
    J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis and aromatase inhibitors.
    Bertolini E; Letho-Gyselinck H; Prati C; Wendling D
    Joint Bone Spine; 2011 Jan; 78(1):62-4. PubMed ID: 20621535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous leukocytoclastic vasculitis associated with letrozole.
    Digklia A; Tzika E; Voutsadakis IA
    J Oncol Pharm Pract; 2014 Apr; 20(2):146-8. PubMed ID: 23676512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.